These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2878386)

  • 1. On the presence of a nondopaminergic, peptidergic prolactin release-inhibiting factor in hypothalamic extracts of infantile rats.
    Khorram O; McCann SM
    Neuroendocrinology; 1986; 44(1):65-9. PubMed ID: 2878386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of alpha-melanocyte-stimulating hormone on basal and stimulated release of prolactin: evidence for dopaminergic mediation.
    Khorram O; Mizunuma H; McCann SM
    Neuroendocrinology; 1982 Jun; 34(6):433-7. PubMed ID: 7099389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin-releasing and release-inhibiting factor activities in the bovine, rat, and human pineal gland: in vitro and in vivo studies.
    Blask DE; Vaughan MK; Reiter RJ; Johnson LY; Vaughan GM
    Endocrinology; 1976 Jul; 99(1):152-62. PubMed ID: 7446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of a non-dopaminergic and non-GABAergic prolactin release-inhibiting factor (PIF) in sheep stalk-median eminence.
    Mizunuma H; Khorram O; McCann SM
    Proc Soc Exp Biol Med; 1985 Jan; 178(1):114-20. PubMed ID: 2857051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of dopaminergic and peptidergic factors in the control of prolactin release.
    Mogg RJ; Samson WK
    Endocrinology; 1990 Feb; 126(2):728-35. PubMed ID: 2298169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent inhibition of prolactin secretion by dopamine and gamma-aminobutyric acid in vitro.
    Enjalbert A; Ruberg M; Arancibia S; Fiore L; Priam M; Kordon C
    Endocrinology; 1979 Sep; 105(3):823-6. PubMed ID: 467339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nonoxytocinergic prolactin releasing factor and a nondopaminergic prolactin inhibiting factor in bovine neurointermediate lobe extracts: in vitro and in vivo studies.
    Samson WK; Martin L; Mogg RJ; Fulton RJ
    Endocrinology; 1990 Mar; 126(3):1610-7. PubMed ID: 2106431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamic control of prolactin secretion during the perinatal period in the rat.
    Khorram O; Depalatis LR; McCann SM
    Endocrinology; 1984 Nov; 115(5):1698-704. PubMed ID: 6436004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ontogeny of prolactin releasing and inhibiting activities in the posterior pituitary of male rats.
    Laudon M; Hyde JF; Ben-Jonathan N
    Neuroendocrinology; 1989 Dec; 50(6):644-9. PubMed ID: 2515464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rat posterior pituitary contains a potent prolactin-releasing factor: studies with perifused anterior pituitary cells.
    Hyde JF; Murai I; Ben-Jonathan N
    Endocrinology; 1987 Oct; 121(4):1531-9. PubMed ID: 2888647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of hypothalamic prolactin release by veratridine and angiotensin II in the female rat: effect of ovariectomy and estradiol administration.
    DeVito WJ; Stone S; Avakian C
    Neuroendocrinology; 1991 Oct; 54(4):391-8. PubMed ID: 1758581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The preovulatory prolactin surge: an evaluation of the role of dopamine.
    Arbogast LA; Ben-Jonathan N
    Endocrinology; 1988 Dec; 123(6):2690-5. PubMed ID: 3264239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterus of the rat contains prolactin inhibitory activity.
    Gorospe WC; Freeman ME
    Am J Physiol; 1984 Aug; 247(2 Pt 1):E251-7. PubMed ID: 6431826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of age and long term ovariectomy on prolactin secretion, as assessed by the reverse hemolytic plaque assay.
    Sortino MA; Wise PM
    Endocrinology; 1989 Jan; 124(1):90-6. PubMed ID: 2491812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a physiological role for oxytocin in the control of prolactin secretion.
    Samson WK; Lumpkin MD; McCann SM
    Endocrinology; 1986 Aug; 119(2):554-60. PubMed ID: 3732136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraventricular administration of histidyl-proline-diketopiperazine [Cyclo(His-Pro)] suppresses prolactin secretion and synthesis: a possible role of Cyclo(His-Pro) as dopamine uptake blocker in rat hypothalamus.
    Jikihara H; Ikegami H; Koike K; Wada K; Morishige K; Kurachi H; Hirota K; Miyake A; Tanizawa O
    Endocrinology; 1993 Mar; 132(3):953-8. PubMed ID: 7679984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further evidence on the role of the hypothalamic afferents on the estrogen-induced prolactin release.
    Caligaris L; Taleisnik S
    Neuroendocrinology; 1977; 23(6):323-9. PubMed ID: 22826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A possible role of prostacyclin to stimulate prolactin and growth hormone release by hypothalamic and pituitary actions, respectively.
    Ottlecz A; Samson WK; McCann SM
    Endocrinology; 1984 Feb; 114(2):359-63. PubMed ID: 6418530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence in favour of the existence of a dopamine-free prolactin-inhibiting factor (PIF) in rat hypothalamic extracts.
    Enjalbert A; Priam M; Kordon C
    Eur J Pharmacol; 1977 Jan; 41(2):243-4. PubMed ID: 12991
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurotensin stimulation of prolactin secretion in vitro.
    Enjalbert A; Arancibia S; Priam M; Bluet-Pajot MT; Kordon C
    Neuroendocrinology; 1982 Feb; 34(2):95-8. PubMed ID: 7070589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.